A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(79 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama Mayo Clinic (Arizona), Scottsdale, Arizona University of Arkansas - Winthrop P. Rockefeller Cancer Institute, Little Rock, Arkansas USC Norris Comprehensive Cancer Center, Los Angeles, California Sansum Clinic, Santa Barbara, California Providence Medical Foundation, Santa Rosa, California Rocky Mountain Cancer Center, Denver, Colorado Sarah Cannon Research Institute at HealthONE, Denver, Colorado Florida Cancer Specialists, Fort Myers, Florida Mayo Clinic (Florida), Jacksonville, Florida Cancer Specialists of North Florida, Jacksonville, Florida Florida Cancer Specialists, Orlando, Florida Florida Cancer Specialists, Sarasota, Florida Florida Cancer Specialists, West Palm Beach, Florida Hope and Healing Cancer Services, Hinsdale, Illinois Community Health Network, Indianapolis, Indiana Our Lady of the Lake, Baton Rouge, Louisiana Maryland Oncology Hematology - Primary, Columbia, Maryland Minnesota Oncology Hematology, Maple Grove, Minnesota Mayo Clinic (Minnesota), Rochester, Minnesota Washington University, St Louis, Missouri Hematology Oncology Associates of Central New York, East Syracuse, New York Northwell Health Cancer Institute, Lake Success, New York Oncology Hematology Care Primary, Cincinnati, Ohio Taylor Cancer Research Center, Maumee, Ohio Stephenson Cancer Center, Oklahoma City, Oklahoma Oregon Health & Science University, Portland, Oregon University of Pennsylvania / Abramson Cancer Center, Philadelphia, Pennsylvania Thomas Jefferson University, Sidney Kimmel Cancer Center, Clinical Research Organization, Philadelphia, Pennsylvania Tennessee Oncology, PLLC, Chattanooga, Tennessee Baptist Cancer Center, Memphis, Tennessee SCRI Oncology Partners, Nashville, Tennessee Texas Oncology - Central/South Texas, Austin, Texas Mary Crowley Cancer Research, Dallas, Texas Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, Texas Texas Oncology - Northeast Texas, Flower Mound, Texas Oncology Consultants, Houston, Texas Texas Oncology - San Antonio, San Antonio, Texas Utah Cancer Specialists, Salt Lake City, Utah Virginia Cancer Specialists, Fairfax, Virginia France
Institut Gustave Roussy, Villejuif, Cedex Institut Bergonie, Bordeau Marseille University Hospital Timone, Marseille Saint-Louis Hospital, Paris Hospital de la Pitié-Salpêtrière, Paris Spain
Hospital General Universitario de Elche, Elche, Alicante H. Parc Tauli, Sabadell, Barcelona Next Oncology Barcelona, IOB, Barcelona, Catalonia Hospital Arnau de Vilanova, Lleida, Catalonia Hospital Universitario La Paz, Madrid, Madrid Next - Hospital Quironsalud Madrid, Pozuelo de Alarcón, Madrid Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia Clínica Universidad de Navarra, Madrid, Planta -2 Hospital Clínico Universitario de Santiago (CHUS), A Coruña Hospital Teresa Herrera (CHUAC), A Coruña Institut Català d'Oncologia Badalona - Hospital Germans Trias i Pujol, Badalona Vall d'Hebron Institute of Oncology (VIHO), Barcelona Hospital Clinic de Barcelona, Barcelona United Kingdom
Beatson West of Scotland Cancer Centre, Glasgow Guy's and St Thomas' NHS Foundation Trust, London Sarah Cannon Research Institute UK, London The Christie NHS Foundation Trust - The Christie Clinic, Manchester ICO Hospitalet, Barcelona
Hospital Universitario Reina Sofia de Córdoba, Córdoba Hospital Universitari Doctor Josep Trueta- ICO de Girona, Girona Hospital General Universitario Gregorio Marañón, Madrid MD Anderson Cancer Center (Madrid, Madrid Hospital Clinico San Carlos, Madrid START Madrid Fundacion Jimenez Diaz, Madrid Hospital Universitario 12 de Octubre, Madrid START Madrid (Hospital San Chinarro), Madrid Hospital Universitario Virgen de la Victoria, Málaga Hospital Universitario De Navarra, Pamplona Hospital Virgen Macarena, Seville Hospital Virgen del Rocío, Seville Instituto Valenciano de Oncología (IVO), Valencia Incliva Biomedical Research Institute, University of Valencia, Valencia Hospital Universitario Miguel Servet, Zaragoza